Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6064757 | Journal of Allergy and Clinical Immunology | 2015 | 10 Pages |
Abstract
The present pilot study shows that clinical-grade depletion of naive T cells from an allograft through the use of magnetic CD45RA beads seems to be a feasible and efficacious option for the treatment of patients with CIDs at high risk of GVHD, infection, or both in an HLA-mismatched setting.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Fabien MD, PhD, Bénédicte MD, PhD, Liliane MD, Aurélie MSc, Despina MD, PhD, Guilhem MD, Maryline MD, Jean-Marc PGDipMLSc, Brigitte PGDipMLSc, Jérémy PharmD, MSc, Capucine MD, PhD, Stéphane MD, Alain MD, PhD, Marina MD, PhD,